Eton's Rezipres (ephedrine hydrochloride injection) Receives the US FDA's Approval for the Treatment of Hypotension
Shots:
- The US FDA has approved Rezipres for the treatment of hypotension that occurs in the setting of anesthesia
- Rezipres is a sulfite-free formulation that has been sold successfully in the EU for years. Additionally- the company is expected to make it available for US patients shortly
- Currently- the company receives royalties from four FDA-approved products- including Alkindi Sprinkle- Biorphen- Rezipres- and Alaway Preservative Free- and has five additional products that have been submitted to the FDA
| Ref: Globe Newswire | Image: Linkedin
Click here to read the full press release
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com